ClinConnect ClinConnect Logo
Search / Trial NCT06213090

Patterns of Neurodevelopmental Disorders

Launched by RICHARD FRYE · Jan 16, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The "Patterns of Neurodevelopmental Disorders" clinical trial is designed to study various conditions that affect brain development, including Autism Spectrum Disorder, Down Syndrome, and Epilepsy, among others. The goal of this research is to carefully look at the results of medical tests to find common patterns in symptoms and possible causes of these disorders. This could help improve understanding and treatment options for affected individuals.

To participate in this study, you or your child should be experiencing developmental delays and have had a clinical visit at the Rossignol Medical Center. The trial is open to individuals of all ages and genders. If you join, you can expect to undergo a series of evaluations and tests that will help researchers gather important information about these disorders. By participating, you could help pave the way for better insights into neurodevelopmental disorders, which might benefit many families in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Neurodevelopmental delays Clinical visit at an Rossignol Medical Center
  • Exclusion Criteria:
  • -

About Richard Frye

Richard Frye is a distinguished clinical trial sponsor known for his commitment to advancing medical research and enhancing patient care. With extensive expertise in neuroscience and pediatric neurology, he leads innovative studies aimed at understanding and treating complex neurological conditions. His focus on collaborative research efforts fosters interdisciplinary approaches, ensuring that trials are designed to meet the highest scientific and ethical standards. Through his leadership, Richard Frye aims to bridge the gap between research and clinical practice, ultimately improving therapeutic outcomes for patients.

Locations

Phoenix, Arizona, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported